View the complete range of antibiotic discs in cartridges

View the complete range of antibiotic discs in canister packaging

Antibiotic discs
Antibiotic Disc: Instructions for Use rev.18 - 20/07/2023
Antibiotic Disc Interpretative Criteria and Quality Control rev.20 - 08/07/2025
Non-hazardous Product Statement Antibiotic-Antifungal Disc rev.2 - 17/04/2023
EC declaration of conformity according to Directive 98/79/EC rev.37.8 - 22/05/2022
EU declaration of conformity according to IVDR 2017/746 rev.3 - 23/12/2025
Individual drug technical sheet
Amikacin AK 30 mcg disc - IVDR rev.0 - 19/12/2025
Amoxicillin-clavulanic acid (20+10) AUG 30 mcg disc - IVDR rev.0 - 19/12/2025
Ampicillin AMP 2 mcg disc - IVDR rev.0 - 19/12/2025
Aztreonam ATM 30 mcg disc - IVDR rev.0 - 19/12/2025
Chloramphenicol C 30 mcg disc - IVDR rev.0 - 19/12/2025
Ceftazidime CAZ 10 mcg disc - IVDR rev.0 - 19/12/2025
Cefixime CFM 5 mcg disc - IVDR rev.0 - 19/12/2025
Ceftibuten CTB 30 mcg disc - IVDR rev.0 - 19/12/2025
Cefotaxime CTX 5 mcg disc - IVDR rev.0 - 19/12/2025
Cefoxitin FOX 30 mcg disc - IVDR rev.0 - 19/12/2025
Clindamycin CD 2 mcg disc - IVDR rev.0 - 19/12/2025
Erythromycin E 15 mcg disc - IVDR rev.0 - 19/12/2025
Ertapenem ETP 10 mcg disc - IVDR rev.0 - 19/12/2025
Fusidic Acid FC 10 mcg disc - IVDR rev.0 - 19/12/2025
Gentamicin CN 10 mcg disc - IVDR rev.0 - 19/12/2025
Gentamicin CN 30 mcg disc - IVDR rev.0 - 19/12/2025
Aztreonam-avibactam 50 mcg disc - IVDR rev.1 - 10/10/2025
Cefepime-emmetazobactam 50 mcg disc - IVDR rev.1 - 10/10/2025
Imipenem-relebactam 35 mcg disc - IVDR rev.1 - 10/10/2025
Sulopenem 2 mcg disc - US FDA cleared rev.0 - 12/08/2025
Ceftobiprole 5 mcg disc - US FDA cleared rev.1 - 23/06/2025
Oritavancin 5 mcg disc - IVDD rev.1 - 22/03/2022
Cefiderocol 30 mcg disc - IVDD rev.1.1 - 12/05/2021
Antifungal discs
Antifungal disc: Instructions for Use rev.9 - 02/07/2021
Non-hazardous Product Statement Antibiotic-Antifungal Disc rev.2 - 17/04/2023
EC declaration of conformity according to Directive 98/79/EC rev.37.7 - 22/05/2022

Multodiscs
Multodisc: Instructions for Use rev.1.1 - 17/06/2021
VETMultodisc rev.0 - 04/02/2020
Non-hazardous Product Statement Multodiscs rev.0 - 21/03/2018
Disc kits for resistance mechanisms detection
99002 EUCAST ESBL disc kit rev.1 - 06/02/2024
99003 KPC&MBL disc kit (acc. to EUCAST) rev.2.2 - 29/07/2016
99004 ESBL disc kit (acc. to EUCAST) rev.1 - 06/02/2024
99005 ESBL disc kit (acc. to CLSI) rev.0.1 - 31/08/2015
99006 ESBL (Chromos. Ind. AmpC) disc kit (acc. to EUCAST) rev.1 - 06/02/2024
99007 KPC&MBL&OXA-48 disc kit (acc. to EUCAST) rev.1 - 17/06/2016
99008 ESBL+AmpC screen disc kit rev.0.1 - 31/08/2015
99009 AmpC disc kit rev.0.1 - 08/09/2015
ESBL disc tests rev.2 - 19/06/2014
Non-hazardous Product Statement Disc Kits for Antimicrobial Resistance Testing rev.0 - 14/12/2018
Brochure
Lot specific e-IFU

Accessories for antimicrobial susceptibility testing

Rotating Plate Inoculator for confluent microbial growth


MIC Test Strip

Services

1. D-value and Z-value determination

Liofilchem performs D-Value and Z-Value analysis by direct inoculation of product or equipment using Biological Indicator Organisms (BI's).
The test is mainly used to verify the labeled D-value of BIs to confirm their suitability for use and to determine the resistance of inoculated products, process challenge devices (PCDs), isolates recovered from bioburden tests, environmental monitoring, product sterility tests.

D-values are stated by the manufacturer on the BIs but often require verification for a higher degree of accuracy and process specificity.
SAL should always be established in relation to a D-value that is higher than that of the natural bioburden at routine production.

D-value evaluation

Our Biological Indicator Evaluation Resistometer (BIER) Vessel autoclave verifies the Dvalue by accurately delivering a calibrated and pre-determined level of lethality, such as a steam sterilisation at 121°C, 118°C and 132°C.
The log reduction achieved for exposure time is assessed through the exposure of the BI for defined time points and interpretation via fractional analysis.
This process allows the accurate verification of the manufacturer’s stated D-value.
The use of appropriate biological indicators, with a D-value that is representative of (and not lower than) the thermal resistance of the indigenous environmental bioburden, is a key element of the Contamination Control Strategy (CCS) and supports the demonstration that a validated sterilisation process achieves the required Sterility Assurance Level (SAL).
Bioburden characterization became mandatory requirement when the overkill approach is not used (refer to EMA CPMP 2015).

-value evaluation

Equipment & Method

The design of the BIER vessel, the maintenance schedule, and the utilities employed are fully aligned with pharmaceutical industry standards. This ensures the precise and consistently reproducible determination of microbial resistance, closely simulating the actual conditions under which the biological indicator will be used by the customer. Such rigour delivers not only scientific accuracy but also tangible value for clients seeking the highest reliability in their sterilisation validation processes.

- Equipment

D value is performed in an internal laboratory certified by TÜV Süd to ISO 9001 for the quality management. The BIER vessel is a Fedegari FOB series design compliant to ANSI/AAMI/ ISO 18472 requirements Sterilization of Health Care Product - Biological and Chemical Indicators and designed to create precise and repeatable sterilizing environments, allowing the evaluation of their effect on biological inactivation kinetics, chemical reactions, material degradation and product bioburden.
BIER Resistometer allows precise variation of the environmental conditions and cycle sequences in order to produce controlled physical studies.

- Measurement Accuracy (Maintenance, Calibration, Monitoring)

  • The probes used to measure temperature and pressure from within the steam resistometer are annually certified.
  • Re-qualification of the equipment is performed annually.
  • Purified water system subjected to biweekly chemical and microbiological checks.
  • Steam meets the requirements of the Non-Condensable Gases (NCG) test is compliant with steam quality standards necessary for moist-heat sterilization.
  • A preventive maintenance plan for the equipment’s critical components is in place.

- Method

Stumbo-Murphy-Cochran, Holcomb-Spearman-Karber, and Limited HolcombSpearman-Karber methods could be used according to ANSI/AAMI/ISO 11138.


2. Biological Indicator Population - Total Viable Spore Count

Population Verification (Spore Counts) is performed before the D-value determination to confirm that the microbial population within a batch of BIs matches the manufacturer’s Certificate of Analysis.
Heat Shocked and Non-Heat Shocked, Pooled or Individual BIs is verified according to USP or ISO 11138-1- Sterilization of health care products- Biological Indicators.

3. Customized biological indicators

Customized BIs are essential in situations where a standard BI would not provide an adequate challenge to the sterilization process, they may not accurately mimic the specific size, shape, and material of a unique product.
Products like vial stoppers i.e. present sterilization challenges due to their various configurations and materials, requiring a custom BI for a truly accurate result.
Liofilchem is available to prepare ad hoc BIs according to customers’ requirements.
In this application, using the D-value to determine resistance is essential for certifying the biological indicator and ensuring compliance with ISO standards and regulatory requirements.

4. Fit-for-purpose studies

Further studies may be required to deepen understanding of biological indicators and products, and to enhance internal processes. For example, BI transport qualification confirms retention of population characteristics and resistance during shipping, in accordance with ISO 11138-7.
Liofilchem can support your company with these studies, aligned with to your needs.

-value evaluation

References

European Pharmacopoeia (Ph. Eur.) 10th Edition, Biological Indicators of Sterilization.


US Pharmacopeia, current version, USP–NF 2021, Biological Indicators Resistance Performance Test.


ISO 11138-1:2017 Sterilization of health care products — Biological indicators — Part 1: General requirements.


ISO 11138-2:2017 Sterilization of health care products — Biological indicators — Part 2: Biological indicators for ethylene oxide sterilization processes.


ISO 11138-3:2017 Sterilization of health care products — Biological indicators — Part 3: Biological indicators for moist heat sterilization processes.


ISO 11138-4:2017 Sterilization of health care products — Biological indicators — Part 4: Biological indicators for dry heat sterilization processes.


ISO 11138-7:2017 Sterilization of health care products — Biological indicators — Part 7: Guidance for the selection, use interpretation of results.


European Medicines Agency (EMA). Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container. EMA/CHMP/CVMP/QWP/850374/2015


Page 1 of 2